ValueAct Holdings, L.P. is Director at Valeant Pharmaceuticals International, Inc. (VRX). They have made 52 open-market trades across 22 companies since 2008, most recently 2024-06-03.
25 open-market purchases totalling $504.5M since 2009, against 27 sales. Across 23 scored buys the stock is up 2.8% at ninety days, and 0.4 points ahead of the S&P over the same stretch.
23 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 26% | 78% | 83% |
| Avg Move | -5.6% | +1.3% | +2.8% |
| Alpha | -3.4% | +0.8% | +0.4% |
| Scored | 23 | 23 | 23 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 81% | 33% | 41% |
| Avg Move | -3.2% | -0.0% | -0.9% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRM | BUY | 2024-06-03 | 2024-06-05 | $233.17 | $99.8M | -3.9% | +9.7% | +3.4% |
| NSIT | BUY | 2022-05-23 | 2022-05-25 | $95.71 | $19.1M | +7.7% | -9.6% | -2.2% |
| CBRE | SELL | 2021-08-10 | 2021-08-12 | $96.06 | $96.1M | -2.6% | +2.7% | +10.0% |
| STX | SELL | 2020-12-29 | 2020-12-31 | $61.20 | $173.1M | -3.9% | +7.1% | +23.2% |
| AES | BUY | 2019-08-12 | 2019-08-14 | $15.25 | $3.0M | -0.7% | +5.7% | +20.9% |
| AFI | SELL | 2019-06-21 | 2019-06-21 | $11.10 | $75.5M | -4.3% | -19.1% | -35.6% |
| AES | BUY | 2018-12-26 | 2018-12-28 | $13.75 | $481K | +6.1% | +9.8% | +25.2% |
| UFI | BUY | 2018-11-19 | 2018-11-21 | $26.84 | $1.6M | -4.9% | -19.7% | -14.8% |
| UFI | BUY | 2018-11-06 | 2018-11-08 | $26.46 | $1.8M | -0.4% | -9.7% | -21.8% |
| TRN | BUY | 2018-03-15 | 2018-03-19 | $32.77 | $29.5M | -0.8% | -2.9% | +4.2% |
| AWI | SELL | 2018-03-12 | 2018-03-14 | $59.60 | $140.1M | -3.3% | -4.6% | +9.7% |
| CBG | SELL | 2017-11-28 | 2017-11-30 | $42.25 | $188.7M | -0.3% | +0.8% | +7.5% |
| WLTW | SELL | 2017-10-11 | 2017-10-13 | $156.74 | $90.1M | +3.2% | +2.1% | -2.1% |
| WLTW | SELL | 2017-09-18 | 2017-09-20 | $152.38 | $12.6M | +2.1% | +6.9% | +1.2% |
| TRN | BUY | 2017-08-29 | 2017-08-31 | $28.63 | $8.1M | +1.7% | +21.8% | +21.8% |
| WLTW | SELL | 2017-05-31 | 2017-06-02 | $145.07 | $8.0M | +0.4% | -0.7% | +0.7% |
| MSFT | SELL | 2017-05-03 | 2017-05-05 | $68.84 | $757.2M | -2.2% | +4.8% | +4.6% |
| VRX | BUY | 2017-03-14 | 2017-03-16 | $10.82 | $32.5M | -6.9% | -17.3% | +8.6% |
| CBG | BUY | 2016-11-07 | 2016-11-09 | $26.95 | $32.3M | +3.8% | +18.8% | +12.2% |
| CBG | BUY | 2016-11-02 | 2016-11-04 | $25.79 | $98.9M | +2.1% | +12.3% | +12.7% |
| MSCI | SELL | 2016-09-22 | 2016-09-26 | $86.68 | $10.9M | -2.5% | -2.8% | -7.5% |
| MSCI | SELL | 2016-09-14 | 2016-09-16 | $85.28 | $19.2M | -0.5% | -2.9% | -5.6% |
| MSCI | SELL | 2016-09-06 | 2016-09-08 | $88.17 | $39.7M | -1.0% | -4.1% | -6.7% |
| CBG | BUY | 2016-08-01 | 2016-08-03 | $28.31 | $42.5M | +2.9% | +4.7% | -10.2% |
| MSI | SELL | 2016-03-15 | 2016-03-17 | $72.39 | $64.9M | +2.6% | +3.7% | -7.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| IT | 3,933,120 | $807.5M |
| WLTW | 2,916,173 | $675.3M |
| NSIT | 3,899,226 | $626.6M |
| TRN | 20,763,695 | $523.5M |
| VRX | 16,937,431 | $396.3M |
| KAR | 8,845,045 | $273.1M |
| AES | 4,346,500 | $65.0M |
| CIM | 4,375,428 | $36.8M |
| AMPS | 4,017,628 | $20.0M |
| EYE | 642,803 | $11.2M |
| UFI | 1,127,679 | $6.4M |
| BHC | 948,353 | $6.0M |
| STX | 9,009 | $5.8M |
| AWI | 7,295 | $1.2M |
| NKLA | 6,675,437 | $1.2M |
| ALSN | 6,925 | $774K |
| MSCI | 900 | $512K |
| AFI | 1,222,756 | $429K |
| ADS | 1,219 | $69K |
| BLUD | 6,964,182 | — |
| WSH | 18,280,600 | — |
| Total | $16.8B |
Shares reported on the most recent Form 4, priced at the 2024-06-05 close. 2 holdings could not be priced and are excluded from the total.
| Scored | 27 | 27 | 27 |